TRODELVY® (sacituzumab govitecan-hziy) is a prescription medicine used to treat adults with hormone receptor (HR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has spread to other parts of the body (metastatic) or cannot be removed by surgery, and who previously received endocrine therapy and at least two additional treatments for metastatic disease. It is not known if TRODELVY is safe and effective in people with moderate or severe liver problems or in children.
If you are looking for support from the community around you, a discussion with others about living with HR+/HER2- mBC, or an opportunity to be an advocate for those who need a guiding hand, there are active groups available for you to explore. Connect with an organization that fits you and your lifestyle.
Providing reliable, easy-to-understand, and actionable information and support resources to help you make the best decisions for your lives.
Ensuring that all people impacted by cancer are empowered by knowledge, strengthened by action, and sustained by community.
Offering on-demand emotional, practical, and evidence-based content that is meaningful to those newly diagnosed, in treatment, posttreatment, and living with metastatic disease.
Working to transform the lives of people with metastatic breast cancer as the national leader in collaborative action, made up of nonprofit cancer organizations from pharmaceutical and biotech industry members to individual patient advocates.
Sustaining hope for those living with stage 4 metastatic breast cancer (mBC) as a volunteer-led, non-profit organization, funding vital research to help improve the longevity and quality of life for mBC patients.
Supporting, educating, and empowering anyone who has been diagnosed with breast or gynecologic cancers, providing outreach to the general public about signs and symptoms. We are a community of survivors, those living with cancer, and healthcare professionals.
Working to create a more equitable and accessible health care system for the Latiné community around issues of cancer.
Working to improve the lives of LGBT cancer survivors and those at risk by educating the LGBT community about risks and screening, and advocating for LGBT survivors in mainstream cancer organizations, the media and research.
Improving the lives of Jewish women and families living with or at increased genetic risk for breast or ovarian cancer through personalized support and saving lives through educational outreach.
Educating and empowering women before, during, and after breast cancer through unique programs for all backgrounds, including those at heightened risk, and those with less access to care.
Providing breast cancer coaching and navigation support in order to disrupt outcome disparities so every patient receives the care they deserve.
Driving the collaborative efforts of patients, survivors, advocates, advocacy organizations, health care professionals, researchers, and pharmaceutical companies to work towards the common goal of eradicating Black Breast Cancer.
Strengthening the community, addressing the unique needs, amplifying the voice, and improving the quality of life of young adults affected by breast cancer locally, nationally, and internationally.
These resources are not controlled or owned by Gilead, and Gilead is not responsible for their content.